Alprolix: Expiry of patents in US/EU/Japan in December 2037 (Sanofi) - Mar 5, 2022 - Annual Report 2021: Expiry of patents related to compound in EU in May 2024 with SPC until May 2029; Expiry of patent related to compound in Japan in February 2026; Expiry of patent related to use in US in March 2028; Regulatory exclusivity in Japan until July 2022 and EU until May 2028; Biologics regulatory exclusivity in US until March 2026
Commercial • Patent • Hemophilia
|